Evidence map›Paper›PMID 26214801›Full record

Trial reportPloS one2015

Automated Peritoneal Dialysis Is Associated with Better Survival Rates Compared to Continuous Ambulatory Peritoneal Dialysis: A Propensity Score Matching Analysis.

Gabriela de Carvalho Beduschi, Ana Elizabeth Figueiredo, Marcia Olandoski, Roberto Pecoits-Filho, Pasqual Barretti, Thyago Proenca de Moraes, all centers that contributed to the BRAZPD

Erratum issued Registry-linked trialOpen access · goldAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05449067 (Nocturnal Automated Versus Continuous Ambulatory Peritoneal Dialysis in Patients With End-Stage Kidney Disease), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05449067 nacompletednot on this mapstarted 2022, after this paper: background citation

Nocturnal Automated Versus Continuous Ambulatory Peritoneal Dialysis in Patients With End-Stage Kidney Disease: A Multicenter, Randomized, Open-Label, Crossover Non-Inferiority Trial

TypeinterventionalSponsorNanfang Hospital, Southern Medical UniversityRan2022 to 2026Enrolled137ConditionsEnd-Stage Kidney Disease, Peritoneal DialysisArmsNocturnal automated peritoneal dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Similar survival on home haemodialysis and automated peritoneal dialysis: an inception cohort study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  9. APD or CAPD: one glove does not fit all.International urology and nephrology · 2021
    Review
  10. Automated Peritoneal Dialysis: Patient Perspectives and Outcomes.International journal of nephrology and renovascular disease · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gabriela de Carvalho BeduschiSchool of Medicine, UNESP, Botucatu, Brazil.
Ana Elizabeth FigueiredoGraduate Program in Medicine and Health Sciences, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
Marcia OlandoskiSchool of Medicine, UNESP, Botucatu, Brazil.
Roberto Pecoits-FilhoSchool of Medicine, UNESP, Botucatu, Brazil.
Pasqual BarrettiSchool of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil.
Thyago Proenca de MoraesSchool of Medicine, UNESP, Botucatu, Brazil.
all centers that contributed to the BRAZPD
Universidade Estadual Paulista (Unesp) · BRPontifícia Universidade Católica do Paraná · BRPontifícia Universidade Católica do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe impact of peritoneal dialysis modality on patient survival and peritonitis rates is not fully understood, and no large-scale randomized clinical trial (RCT) is available. In the absence of a RCT, the use of an advanced matching procedure to reduce selection bias in large cohort studies may be the best approach. The aim of this study is to compare automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) according to peritonitis risk, technique failure and patient survival in a large nation-wide PD cohort.

methodsThis is a prospective cohort study that included all incident PD patients with at least 90 days of PD recruited in the BRAZPD study. All patients who were treated exclusively with either APD or CAPD were matched for 15 different covariates using a propensity score calculated with the nearest neighbor method. Clinical outcomes analyzed were overall mortality, technique failure and time to first peritonitis. For all analysis we also adjusted the curves for the presence of competing risks with the Fine and Gray analysis.

resultsAfter the matching procedure, 2,890 patients were included in the analysis (1,445 in each group). Baseline characteristics were similar for all covariates including: age, diabetes, BMI, Center-experience, coronary artery disease, cancer, literacy, hypertension, race, previous HD, gender, pre-dialysis care, family income, peripheral artery disease and year of starting PD. Mortality rate was higher in CAPD patients (SHR1.44 CI95%1.21-1.71) compared to APD, but no difference was observed for technique failure (SHR0.83 CI95%0.69-1.02) nor for time till the first peritonitis episode (SHR0.96 CI95%0.93-1.11).

conclusionIn the first large PD cohort study with groups balanced for several covariates using propensity score matching, PD modality was not associated with differences in neither time to first peritonitis nor in technique failure. Nevertheless, patient survival was significantly better in APD patients.

Indexed as

Propensity ScoreAdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansMaleMiddle AgedPeritoneal Dialysis, Continuous AmbulatoryProspective StudiesRisk FactorsSurvival Rate

Identifiers

PMID26214801
PMCPMC4516259
OpenAlexW1021876372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.